Search Results - "Alberts, Arnout R"

Refine Results
  1. 1

    Prostate-specific antigen-based prostate cancer screening: Past and future by Alberts, Arnout R, Schoots, Ivo G, Roobol, Monique J

    Published in International journal of urology (01-06-2015)
    “…Prostate‐specific antigen‐based prostate cancer screening remains a controversial topic. Up to now, there is worldwide consensus on the statement that the…”
    Get full text
    Journal Article
  2. 2

    Biomarker-Oriented Therapy in Bladder and Renal Cancer by Scholtes, Mathijs P, Alberts, Arnout R, Iflé, Iris G, Verhagen, Paul C M S, van der Veldt, Astrid A M, Zuiverloon, Tahlita C M

    “…Treatment of patients with urothelial carcinoma (UC) of the bladder or renal cancer has changed significantly during recent years and efforts towards…”
    Get full text
    Journal Article
  3. 3

    Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans by Alberts, Arnout R, Schoots, Ivo G, Bokhorst, Leonard P, van Leenders, Geert J, Bangma, Chris H, Roobol, Monique J

    Published in European urology (01-06-2016)
    “…Abstract Background Multiparametric magnetic resonance imaging (mpMRI) is increasingly used in men with suspicion of prostate cancer (PCa) after negative…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Additional benefit of using a risk‐based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer by Chiu, Peter K., Alberts, Arnout R., Venderbos, Lionne D. F., Bangma, Chris H., Roobol, Monique J.

    Published in BJU international (01-09-2017)
    “…Objective To investigate biopsy complications and hospital admissions that could be reduced by the use of European Randomized Study of Screening for Prostate…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Distribution of Prostate Imaging Reporting and Data System score and diagnostic accuracy of magnetic resonance imaging–targeted biopsy: comparison of an Asian and European cohort by Zhang, Kai, Chen, Rui, Alberts, Arnout R., Zhu, Gang, Sun, Yinghao, Roobol, Monique J.

    Published in Prostate international (01-09-2019)
    “…This study aimed to compare the distribution of Prostate Imaging Reporting and Data System (PI-RADS) score and the diagnostic accuracy of magnetic resonance…”
    Get full text
    Journal Article
  8. 8

    Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam by Alberts, Arnout R, Bokhorst, Leonard P, Kweldam, Charlotte F, Schoots, Ivo G, Kwast, Theo H, Leenders, Geert J, Roobol, Monique J

    Published in International journal of urology (01-04-2017)
    “…Objectives A total of 15 men who died of prostate cancer had cT1/2 biopsy Gleason score ≤6 prostate cancer at prevalence screening in the European Randomized…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers by Bokhorst, Leonard P, Alberts, Arnout R, Rannikko, Antti, Valdagni, Riccardo, Pickles, Tom, Kakehi, Yoshiyuki, Bangma, Chris H, Roobol, Monique J

    Published in European urology (01-11-2015)
    “…Abstract Background Men with prostate cancer on active surveillance (AS) are advised to follow strict follow-up schedules and switch to definitive treatment on…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Shifting risk‐stratified early prostate cancer detection to a primary healthcare setting by Hogenhout, Renée, Osses, Daniël F., Alberts, Arnout R., Buizer‐Rijksen, Hanne G., Remmers, Sebastiaan, Roobol, Monique J.

    Published in BJU international (01-05-2023)
    “…Objective To evaluate the feasibility of multivariable risk stratification for early prostate cancer (PCa) detection in a primary healthcare diagnostic…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Stadium IIA/B-seminoma testis: retroperitoneale lymfeklierdissectie als alternatief voor chemotherapie en radiotherapie? by Alberts, Arnout R., Zuiverloon, Tahlita C. M.

    Published in Tijdschrift voor urologie (01-10-2023)
    “…Samenvatting De standaardbehandeling voor stadium IIA-seminoma testis (1 tot 5 vergrote retroperitoneale lymfeklieren ≤ 2 cm) en stadium IIB-seminoma testis…”
    Get full text
    Journal Article
  17. 17

    Multivariable risk-based patient selection for prostate biopsy in a primary health care setting: referral rate and biopsy results from a urology outpatient clinic by Osses, Daniël F, Alberts, Arnout R, Bausch, Gonny C F, Roobol, Monique J

    Published in Translational andrology and urology (01-02-2018)
    “…According to their guidelines, Dutch general practitioners (GPs) refer men with prostate-specific antigen (PSA) level ≥3.0 ng/mL to the urologist for…”
    Get full text
    Journal Article
  18. 18

    Targeted therapies in bladder cancer: an overview of in vivo research by van Kessel, Kim E. M., Zuiverloon, Tahlita C. M., Alberts, Arnout R., Boormans, Joost L., Zwarthoff, Ellen C.

    Published in Nature reviews. Urology (01-12-2015)
    “…Key Points Over the past 20 years, survival of patients with muscle-invasive bladder cancer has not improved None of the targeted therapies that are approved…”
    Get full text
    Journal Article
  19. 19

    Case report. Scrotaal maligne mesothelioom by Straten, Frederika J., Alberts, Arnout R., Zuiverloon, Tahlita C. M., van den Broeke, Pieter J.

    Published in Tijdschrift voor urologie (01-08-2024)
    “…Samenvatting Het scrotaal maligne mesothelioom is een agressieve tumor die uitgaat van de tunica vaginalis. Het zeldzame karakter en de atypische presentatie…”
    Get full text
    Journal Article
  20. 20